Arronax Nantes brings together all stakeholders in Nantes working on research and development in nuclear medicine.

This more particularly include the GIP ARRONAX, the laboratories CeisamCEMA-OnirisCRCI2NA, LS2NSubatech, the CRIP-Oniris core facility and the Nuclear Medicine departments of the University Hospital of Nantes and the ICO.

Arronax Nantes is a stakeholder in the I-SITE NExT, in close collaboration with the LabEx IRON and the SIRIC ILIAD.

our publications

  • Methodology for small animals targeted irradiations at conventional and ultra-high dose rates 65 MeV proton beam, Evin M, Koumeir C, Bongrand A, Delpon G, Haddad F, Mouchard Q, et al., Physica Medica., 1 avr 2024;120:103332.

  • Validation of the ΔSUVmax for interim PET interpretation in diffuse large B-cell lymphoma on the basis of the GAINED clinical study. Itti E, Blanc-Durand P, Berriolo-Riedinger A, Kanoun S, Kraeber-Bodéré F, Meignan M, Gat E, Le Gouill S, Casasnovas RO, Bodet-Milin C. J Nucl Med. 2023, 64: 1706-1711.

our news

Our equipments